Benzinga | Nov 3, 2021 05:41PM EDT

Adaptive Biotechnologies Q3 EPS $(0.40) Beats $(0.42) Estimate, Sales $39.50M Beat $36.64M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.42) by 4.76 percent. This is a 48.15 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $39.50 million which beat the analyst consensus estimate of $36.64 million by 7.81 percent. This is a 50.20 percent increase over sales of $26.30 million the same period last year.